channels [8, 9] . This phenomenon of Na + channel blockade was also found with local anesthetics in clinical use [10] . Following perisciatic nerve injection, doxepin further produced a significant neural blockade on the sciatic nerve [9, 11] . Following intrathecal injection, doxepin also produced a significant spinal anesthetic effect in a singledose study [12] . These important results suggested that doxepin has a local anesthetic effect. However, although several workers suggested that doxepin has a local anesthetic effect, studies related to its spinal action have been relatively inconclusive. First, no dose-response study was carried out to evaluate the spinal action of doxepin. Second, no duration study was carried out to evaluate the duration of its action. Third, no comparisons were made between doxepin and the traditional local anesthetics on their potencies and duration of action. The aim of our study was to evaluate and compare the potency and duration of the spinal anesthetic effect of doxepin with two commonly used traditional local anesthetics, bupivacaine and lidocaine.
MATERIALS AND METHODS
Male Sprague-Dawley rats, obtained from the National Laboratory Animal Center, Taiwan (weight between 300 and 350 g), were used. They were housed in groups of three for at least 1 week in a climate-controlled room maintained at 21°C with approximately 50% relative humidity. Lighting was on a 12-hour light/dark cycle (lights on at 6:00 a.m.), with food and water available on demand except during the time of testing. Each treatment group (that is, for each drug of each dose) consisted of six rats. All tests were performed in accordance with the recommendations and policies of the International Association for the Study of Pain, and the protocol was approved by the animal investigation committee of Chi-Mei Medical Center.
In part 1 of the study, the potencies of doxepin, bupivacaine, and lidocaine were evaluated for their spinal anesthetic effect. Part 2 evaluated the durations of their spinal anesthetic effect.
Doxepin HCl, bupivacaine HCl, and lidocaine HCl were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All drugs were dissolved in 5% dextrose as a solution. Rats were handled before testing to familiarize them with the experiment and to minimize stress-induced analgesia. The experimenter was blinded to the drugs and dosages used. Intrathecal injections of drugs were performed according to the method reported previously [12] . In brief, the injections of drugs were performed in conscious rats following adequate local anesthesia by infiltration with 1.0% lidocaine (50 µL) around the injection site of lumbar intervertebral space 4 to 5 (L4-5). Following local infiltrative anesthesia, a 27-gauge needle attached to a 100-µL syringe (Hamilton, Reno, NV, USA) was inserted intrathecally through the midline of the L4-5 intervertebral space and 90 µL of drug was instilled. Success in intrathecal injection was confirmed by a sense of 'give' and the sign of a tail flick [12, 13] . Each rat received only one intrathecal injection of drug.
In part 1, the potencies of the drugs' action were evaluated. Following intrathecal injections of drugs (n = 6 rats for each drug of each dose), three neurobehavioral examinations that evaluated motor function, proprioception, and nociception were conducted according to the method reported previously [11, 12] . Briefly, (1) motor function was evaluated by measuring the strength of extensor postural thrust of the hindlimbs of rats, (2) proprioception was evaluated by measuring the functional deficit of a hopping response following waving the animal body while it was standing on just one hindlimb, and (3) nociception was evaluated by measuring the withdrawal reflex or vocalization elicited by pinches of the skinfold over the back 1 cm from the proximal part of the tail, the lateral metatarsus of the bilateral hindlimbs, and the dorsal part of the mid-tail. Rats were tested at 5 minutes before medication, at 1, 5, and 10 minutes afterward, again at 10-minute intervals until 1 hour had passed, and at 15-minute intervals until 2 hours had passed. For consistency, one trained examiner was responsible for all rat handling and behavioral evaluations. The magnitude of spinal blockade (motor function, proprioception, and nociception) was described as the percentage of possible effect (% PE) [12] ; the maximum value of % PE values following each test was presented as percentage of maximum possible effect (% MPE). Doseresponse curves were constructed following tests, and the 50% effective doses (ED 50 values) of the drugs were then obtained from computer-derived curve fitting by SAS NLIN analysis (SAS Institute Inc., Cary, NC, USA) of the doseresponse curves. The ED 50 was defined as the dose of a drug that caused a 50% spinal block of motor function, proprioception, or nociception following intrathecal administration [14] .
In part 2, the durations of the drugs' action were evaluated. The ED 25 and ED 75 values of drugs were obtained from computer-derived curve fitting as described in part 1. Rats then received intrathecal injections of drug at doses of ED 25 , ED 50 , or ED 75 (n = 6 rats for each drug of each dose). However, because there were three ED 50 values for each drug (that is, ED 50 values for motor function, proprioception, and nociception), the mean value of these three ED 50 values was used for injection. The mean values of ED 25 and ED 75 were also obtained by the above method. The duration of the spinal anesthetic effect of drug was defined as the full recovery time of spinal blockade. It was measured as an interval from time zero at the time of injection to the time of complete recovery [11, 12] .
The differences of ED 50 values among drugs were evaluated by using a one-way analysis of variance (ANOVA) followed by the pairwise Tukey HSD test. The differences of duration among drugs were evaluated by a two-way ANOVA followed by the pairwise Tukey HSD test. Statistical significance was defined as p < 0.05.
RESULTS
The effects in rat spinal blockade in motor function, proprioception, and nociception of doxepin and two traditional local anesthetics at various doses were evaluated. Because of the similarities of the values, only those obtained (Figure 1) . At this dose, doxepin provided 81.1%, 84.8%, and 75.0% of blockades (% MPE) in motor function, proprioception, and nociception, respectively, whereas bupivacaine provided 74.2%, 75.2%, and 70.8% of blockades, respectively.
The dose-response curves were constructed following intrathecal injections of drugs of different doses (Figure 2) . The ED 50 values of drugs for the spinal blockades of motor function, proprioception, and nociception are given in the Table. Doxepin, bupivacaine, and lidocaine produced doserelated spinal blockades of motor function, propioception, and nociception. The potency of spinal blockade by doxepin was similar to that of bupivacaine and higher than that of lidocaine (Table) . All rats recovered completely after intrathecal injections of drugs. The durations of spinal blockades of drugs are shown in Figure 3 . Among the drugs evaluated, doxepin had the longest duration of action (p < 0.001, in motor function, proprioception, and nociception).
DISCUSSION
In this study, the potencies and durations of the spinal anesthetic effects of doxepin and two traditional local anesthetics were evaluated and compared. We found that doxepin produced dose-related spinal anesthetic effects of motor function, proprioception, and nociception that were more potent than those of lidocaine and longer lasting than those of bupivacaine and lidocaine. Doxepin, a TCA, has been used in the treatment of major depression and other psychiatric disorders for longer than 40 years [1] . Recently, doxepin and other TCAs have also been used in the treatment of pain [2] [3] [4] [5] [6] 15, 16] . In animal studies, doxepin dose-dependently increased the mechanical pain threshold of the paw in rats [6] . Doxepin given 30 minutes before intraplantar formalin also significantly increased the inflammatory pain threshold of the paw in rats [6] . In human studies, doxepin administered preoperatively significantly decreased postoperative opioid requirements [6] . Doxepin also effectively relieved lower back pain and neuropathic pain in patients [15, 16] . Although doxepin was effective in alleviating pain, the detailed mechanism of its action is not clear [2] . The proposed mechanism was that doxepin, a TCA, might enhance the inhibitory descending cortical, supraspinal, and spinal pathways that might mitigate nociceptive impulses from the peripheral to the central nervous system [2] [3] [4] [5] [6] . This mechanism might involve the inhibition of the reuptake of serotonin and norepinephrine, and the blockade of the muscarinic, cholinergic, histaminergic, α 2 -adrenergic, N-methyl-D-aspartate receptors [2] [3] [4] [5] [6] . Recently, doxepin and several other TCAs were also found to have a blocking effect on Na + conductance by a manner similar to the clinically used local anesthetics [10, 12, 14] . However, although doxepin appeared to have a local anesthetic effect, studies related to the spinal anesthetic effect of doxepin were relatively inconclusive. Here, we demonstrate that doxepin, acting as a local anesthetic, dose-dependently blocked the spinal functions of motor activity, proprioception, and nociception. In comparison with bupivacaine, a potent and long-acting traditional local anesthetic, doxepin produced an equipotent local anesthetic effect but with longer duration of action. This result was valuable, not only pharmacologically, but also clinically. If doxepin is appropriately used, its specific characteristics may further enhance its clinical value in the management of pain. The spinal actions of doxepin may also give some explanations of its clinical effect in pain management. Figure 2 . *p < 0.001 when compared with lidocaine, by using a one-way ANOVA followed by the pairwise Tukey HSD test. The difference between doxepin and bupivacaine was not significant. 
